1. Home
  2. RCUS vs PBH Comparison

RCUS vs PBH Comparison

Compare RCUS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.31

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$61.73

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
PBH
Founded
2015
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2018
2005

Fundamental Metrics

Financial Performance
Metric
RCUS
PBH
Price
$21.31
$61.73
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$29.38
$86.40
AVG Volume (30 Days)
2.1M
439.1K
Earning Date
10-28-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.04
Revenue
$240,000,000.00
$1,110,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.50
P/E Ratio
N/A
$15.20
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$57.25
52 Week High
$26.40
$90.04

Technical Indicators

Market Signals
Indicator
RCUS
PBH
Relative Strength Index (RSI) 41.72 56.85
Support Level $20.35 $59.52
Resistance Level $26.10 $62.14
Average True Range (ATR) 1.48 1.48
MACD -0.61 0.32
Stochastic Oscillator 15.21 83.84

Price Performance

Historical Comparison
RCUS
PBH

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: